EUVIMEDSkopri EUVIMED
Video/Audio

Nicardipine Versus Nifedipine for Postpartum Hypertensive Emergencies in Severe Preeclampsia

Huaqi Yao, Zhi Li, Lu Qian

Journal of Visualized Experiments · 2026

DOI: 10.3791/70410 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Huaqi Yao and 2 co-authors. Institution: Department of Intensive Care Medicine, Huzhou Maternity & Child Health Care Hospital. Major MEDLINE topics: Nifedipine, Nicardipine, Pre-Eclampsia, Calcium Channel Blockers. 23 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Severe preeclampsia (sPE)-induced postpartum hypertensive emergencies (PHEs) pose a threat to maternal safety, requiring rapid and stable blood pressure (BP) control. This protocol describes an observational, non-randomized controlled cohort study designed to evaluate the efficacy and safety of two calcium channel blockers-nicardipine (NIC) and nifedipine (NIF)-in patients with sPE-induced PHEs. Key procedural steps include: retrospective enrollment of 131 eligible patients (67 in the NIC group, 64 in the NIF group) admitted between April 2024 and May 2025; propensity score matching to balance baseline characteristics (e.g., age, gestational age, baseline BP); standardized routine sPE management plus targeted antihypertensive treatment (NIC via continuous intravenous infusion, NIF via oral immediate-release tablets); and systematic monitoring of predefined endpoints (BP control metrics, hemodynamic parameters, biological markers including brain natriuretic peptide [BNP] and D-dimer, adverse events, and short-term maternal outcomes). Statistical analyses will use SPSS 32.0, with appropriate tests for between-group comparisons and covariance analysis to adjust for confounding. This protocol is intended to provide a standardized workflow for comparing the two agents in real-world clinical settings, to inform individualized PHE management-particularly regarding drug selection based on clinical context (e.g., venous access availability, monitoring resources)-and to support evidence-based decision-making for postpartum hypertensive crisis care.

Subjects

MeSH terms (MEDLINE)

NifedipineNicardipinePre-EclampsiaCalcium Channel BlockersAntihypertensive AgentsHumansFemalePregnancyHypertensive CrisisPostpartum PeriodRetrospective Studies

Substances

NifedipineNicardipineCalcium Channel BlockersAntihypertensive Agents

Authors and institutions

  • Department of Intensive Care Medicine, Huzhou Maternity & Child Health Care Hospital.
  • Department of Special Laboratory Examinations, Huzhou Maternity & Child Health Care Hospital.
  • Department of Intensive Care Medicine, Huzhou Maternity & Child Health Care Hospital; qlyyyb2025@163.com.

Cite

APA

Yao, H., Li, Z., & Qian, L. (2026). Nicardipine Versus Nifedipine for Postpartum Hypertensive Emergencies in Severe Preeclampsia. Journal of Visualized Experiments. https://doi.org/10.3791/70410

Vancouver

Yao H, Li Z, Qian L. Nicardipine Versus Nifedipine for Postpartum Hypertensive Emergencies in Severe Preeclampsia. Journal of Visualized Experiments. 2026. doi:10.3791/70410

BibTeX
@article{Yao2026,
  author = {Yao, Huaqi and Li, Zhi and Qian, Lu},
  title = {Nicardipine Versus Nifedipine for Postpartum Hypertensive Emergencies in Severe Preeclampsia},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/70410}
}
Start for free →